Pediatrics Doctors in Indialantic, FL Accepting Medicare

4 Pediatrics doctors found. Showing 1 - 4

Christine D Witte, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1220 N Highway A1a Ste 147, Indialantic, FL 32903 Phone: 321-951-9087    Fax: 321-952-9048

Dr. Sheila Mcleod, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1220 N Highway A1a Ste 147, Indialantic, FL 32903 Phone: 321-951-9087    Fax: 321-952-9048

Arthur Stember, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 408 5th Ave, Indialantic, FL 32903 Phone: 321-724-9900    Fax: 321-724-6609

Carolyn Feltus-atkinson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 325 5th Ave, Indialantic, FL 32903 Phone: 321-821-8449    Fax: 321-821-4890

News Archive

AMA sics drug salesmen on doctors charge groups at annual meeting

The big topic at the American Medical Association's annual meeting this summer was not Michael Moore's Sicko but the AMA's sic-ing drug salesmen on doctors by selling its database.

Researchers develop evidence-based model that can predict amount of nicotine released from e-cigarette

Virginia Commonwealth University Massey Cancer Center researchers at the VCU Center for the Study of Tobacco Products (CSTP) have developed the first ever, evidence-based model that can predict with up to 90 percent accuracy the amount of nicotine emitted by an electronic cigarette (e-cigarette).

Researchers find key protein critical to the success of common anti-platelet drug Plavix

Researchers at the UNC School of Medicine have found that the blood platelet protein Rasa3 is critical to the success of the common anti-platelet drug Plavix, which breaks up blood clots during heart attacks and other arterial diseases.

Ipsen, Oncodesign partner to discover and develop LRRK2 kinase inhibitors against PD

Oncodesign, a Drug Discovery company and Oncology pharmacology service provider, and Ipsen, a global specialty-driven pharmaceutical company, announced today that the two companies have entered into a research collaboration to discover and develop innovative LRRK2 kinase inhibitors as potential therapeutic agents against Parkinson's Disease and for potential additional uses in other therapeutic areas.

Read more Medical News

› Verified 1 days ago